Breast Cancer Clinical Trials in Ohio

Showing 281-300 of 372 trials

Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer

NCT01975363

This randomized pilot clinical trial studies a nanoemulsion formulation of curcumin in reducing inflammatory changes in breast tissue in obese women at high risk for breast cancer. Curcumin may reduce inflammation in breast tissue and fat. This may affect the risk of developing breast cancer.

Atypical Ductal Breast HyperplasiaBRCA1 Gene MutationBRCA2 Gene Mutation+2 more

Ohio State University Comprehensive Cancer Center29 participantsStarted Jun 2013

Columbus, Ohio, United States

COMPLETEDPHASE2/PHASE332 miles

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

NCT01881230

The purpose of this study is to compare the safety and efficacy of nab-paclitaxel in combination with either gemcitabine or carboplatin to the combination of gemcitabine and carboplatin as first line treatment in female subjects with triple negative metastatic breast cancer (TNMBC) or metastatic triple negative breast cancer.

Breast TumorBreast CancerCancer of the Breast+8 more

Celgene191 participantsStarted Sep 2013

Chandler, Arizona, United States • Glendale, Arizona, United States • Scottsdale, Arizona, United States +137 more locations

Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

Breast Cancer Trials in Other Cities

CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)

Circadian Thermal Sensing to Detect Breast Disease

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)

Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)

Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

AirXpanders AeroForm Tissue Expander System for Breast Reconstruction

Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Other Conditions in Ohio